Basic information Safety Supplier Related

PD-L1 inhibitor 1

Basic information Safety Supplier Related

PD-L1 inhibitor 1 Basic information

Product Name:
PD-L1 inhibitor 1
Synonyms:
  • PD-L1 inhibitor 1
  • PD1-PDL1 inhibitor 2
  • N-[2-[[[2-Methoxy-6-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]-3-pyridinyl]methyl]amino]ethyl]acetamide
  • BMS-202
  • Acetamide, N-[2-[[[2-methoxy-6-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]-3-pyridinyl]methyl]amino]ethyl]-
  • PD 1 inhibitor 2
  • PD1 inhibitor 2
  • PD-1 inhibitor 2
CAS:
1675203-84-5
MF:
C25H29N3O3
MW:
419.52
Mol File:
1675203-84-5.mol
More
Less

PD-L1 inhibitor 1 Chemical Properties

Boiling point:
611.4±55.0 °C(Predicted)
Density 
1.133±0.06 g/cm3(Predicted)
storage temp. 
-20°C
solubility 
Soluble in DMSO (up to at least 25 mg/ml) or in Ethanol (up to at least 25 mg/ml)
form 
solid
pka
16.06±0.46(Predicted)
color 
White
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
More
Less

PD-L1 inhibitor 1 Usage And Synthesis

Description

The programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction plays a dominant role in the suppression of T cell responses, especially in a tumor microenvironment, protecting tumor cells from lysis. PD-1/PD-L1 inhibitor 2 is reported to prevent the interaction of PD-L1 with PD-1 with an IC50 value of 18 nM.

Uses

BMS-202 is a Novel inhibitor of the PD-1/PD-L1 interaction by inducing PD-L1 dimerization through PD-1 interacting surface.

in vivo

BMS-202 (20 mg/kg; intraperitoneal injection; daily; for 9 days; NOG-dKO mice) treatment shows a clear antitumor effect compared with the controls, in humanized MHC- dKO NOG mice[2].

Animal Model:NOG-dKO mice (8-week-old) injected with SCC-3 cells[2]
Dosage:20 mg/kg
Administration:Intraperitoneal injection; daily; for 9 days
Result:Showed 41% growth inhibitory activity against humanized mouse-transplanted human lymphoma SCC-3 cells.

References

[1] KRZYSZTOF M ZAK. Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1).[J]. Oncotarget, 2016: 30323-30335. DOI:10.18632/oncotarget.8730
[2] KATARZYNA GUZIK. Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1[J]. Journal of Medicinal Chemistry, 2017, 60 13: 5857-5867. DOI:10.1021/acs.jmedchem.7b00293

PD-L1 inhibitor 1Supplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Beijing HwrkChemical Technology Co., Ltd
Tel
18515581800 18501085097
Email
sales.bj@hwrkchemical.com
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
ShangHai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847 13636370518
Email
shyysw007@163.com
MedChemexpress LLC
Tel
021-58955995
Email
sales@medchemexpress.cn